| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-08 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-08 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.21 |
6e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
| mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.2 |
4e-05 |